β3-Adrenergic Receptors on White and Brown Adipocytes Mediate β3-Selective Agonist-induced Effects on Energy Expenditure, Insulin Secretion, and Food Intake

β3-Adrenergic receptors (β3-ARs) are expressed predominantly on white and brown adipocytes, and acute treatment of mice with CL 316,243, a potent and highly selective β3-AR agonist, produces a 2-fold increase in energy expenditure, a 50–100-fold increase in insulin levels, and a 40–50% reduction in food intake. Recently, we generated gene knockout mice lacking functional β3-ARs and demonstrated that each of these responses were mediated exclusively by β3-ARs. However, the tissue site responsible for producing these actions is unknown. In the present study, genetically engineered mice were created in which β3-ARs are expressed exclusively in white and brown adipocytes (WAT+BAT-mice), or in brown adipocytes only (BAT-mice). This was accomplished by injecting tissue-specific β3-AR transgenic constructs into mouse zygotes homozygous for the β3-AR knockout allele. Control, knockout, WAT+BAT, and BAT-mice were then treated acutely with CL, and the effects on various parameters were assessed. As previously observed, all effects of CL were completely absent in gene knockout mice lacking β3-ARs. The effects on O2 consumption, insulin secretion, and food intake were completely rescued with transgenic re-expression of β3-ARs in white and brown adipocytes (WAT+BAT-mice), demonstrating that each of these responses is mediated exclusively by β3-ARs in white and/or brown adipocytes, and that β3-ARs in other tissue sites were not required. Importantly, transgenic re-expression of β3-ARs in brown adipocytes only (BAT-mice) failed to rescue, in any way, CL-mediated effects on insulin levels and food intake and only minimally restored effects on oxygen consumption, indicating that any effect on insulin secretion and food intake, and a full stimulation of oxygen consumption required the presence of β3-ARs in white adipocytes. The mechanisms by which β3-AR agonist stimulation of white adipocytes produces these responses are unknown but may involve novel mediators not previously known to effect these processes.

[1]  Christophe Fleury,et al.  Uncoupling protein-2: a novel gene linked to obesity and hyperinsulinemia , 1997, Nature Genetics.

[2]  F. Charpentier,et al.  Functional beta3-adrenoceptor in the human heart. , 1996, The Journal of clinical investigation.

[3]  C. Mantzoros,et al.  Activation of β3 Adrenergic Receptors Suppresses Leptin Expression and Mediates a Leptin-Independent Inhibition of Food Intake in Mice , 1996, Diabetes.

[4]  O. Boss,et al.  Respective degree of expression of β1, β2‐ and β3‐adrenoceptors in human brown and white adipose tissues , 1996 .

[5]  P. Ježek,et al.  On the Mechanism of Fatty Acid-induced Proton Transport by Mitochondrial Uncoupling Protein (*) , 1996, The Journal of Biological Chemistry.

[6]  B. Lowell,et al.  Targeted Disruption of the β3-Adrenergic Receptor Gene * , 1995, The Journal of Biological Chemistry.

[7]  J. West Manipulating the Mouse Embryo . A Laboratory Manual, 2nd Edition. By Brigid Hogan, Rosa Beddington, Frank Costantini and Elizabeth Lacy. Cold Spring Harbor Laboratory Press 1994, 497 pages. Price $95. ISBN 0-87969-384-3.--- Either ISSN or Journal title must be supplied. , 1995 .

[8]  R. Devos,et al.  Recombinant mouse OB protein: evidence for a peripheral signal linking adiposity and central neural networks. , 1995, Science.

[9]  M. Pelleymounter,et al.  Effects of the obese gene product on body weight regulation in ob/ob mice. , 1995, Science.

[10]  Steven L. Cohen,et al.  Weight-reducing effects of the plasma protein encoded by the obese gene. , 1995, Science.

[11]  R. Fremeau,et al.  Distribution of β3-adrenoceptor mRNA in human tissues , 1995 .

[12]  P. Ferrara,et al.  Evidence for the presence of β3-adrenergic receptor mRNA in the human brain , 1995 .

[13]  J. Himms-Hagen,et al.  Role of Brown Adipose Tissue Thermogenesis in Control of Thermoregulatory Feeding in Rats: A New Hypothesis That Links Thermostatic and Glucostatic Hypotheses for Control of Food Intake , 1995, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[14]  J. Granneman Why do adipocytes make the β3 adrenergic receptor , 1995 .

[15]  M. Maffei,et al.  Positional cloning of the mouse obese gene and its human homologue , 1994, Nature.

[16]  P. Gilon,et al.  Mechanisms of the Stimulation of Insulin Release by Saturated Fatty Acids: A Study of Palmitate Effects in Mouse β-cells , 1994, Diabetes.

[17]  A. Strosberg,et al.  The promoter and intron/exon structure of the human and mouse beta 3-adrenergic-receptor genes. , 1993, European journal of biochemistry.

[18]  S. Liggett,et al.  Lack of beta 3-adrenergic receptor mRNA expression in adipose and other metabolic tissues in the adult human. , 1993, Molecular pharmacology.

[19]  F. Lönnqvist,et al.  Tissue distribution of beta 3-adrenergic receptor mRNA in man. , 1993, The Journal of clinical investigation.

[20]  J. Granneman,et al.  Rodent and human beta 3-adrenergic receptor genes contain an intron within the protein-coding block. , 1992, Molecular pharmacology.

[21]  G. Bray,et al.  Food intake of lean and obese Zucker rats following ventricular infusions of adrenergic agonists , 1992, Brain Research.

[22]  M. Dutia,et al.  Disodium (R,R)-5-[2-[[2-(3-chlorophenyl)-2-hydroxyethyl]-amino] propyl]-1,3-benzodioxole-2,2-dicarboxylate (CL 316,243). A potent beta-adrenergic agonist virtually specific for beta 3 receptors. A promising antidiabetic and antiobesity agent. , 1992, Journal of medicinal chemistry.

[23]  M. Prentki,et al.  Malonyl-CoA and long chain acyl-CoA esters as metabolic coupling factors in nutrient-induced insulin secretion. , 1992, The Journal of biological chemistry.

[24]  D. Stribling,et al.  ICI D7114: a novel selective adrenoceptor agonist of brown fat and thermogenesis. , 1992, The American journal of clinical nutrition.

[25]  T. Yoshida The antidiabetic beta 3-adrenoceptor agonist BRL 26830A works by release of endogenous insulin. , 1992, The American journal of clinical nutrition.

[26]  J. Venter,et al.  An adipose tissue-specific beta-adrenergic receptor. Molecular cloning and down-regulation in obesity. , 1991, The Journal of biological chemistry.

[27]  M. Mattéi,et al.  Molecular characterization of the mouse beta 3‐adrenergic receptor: relationship with the atypical receptor of adipocytes. , 1991, The EMBO journal.

[28]  J. Granneman,et al.  Molecular cloning and expression of the rat beta 3-adrenergic receptor. , 1991, Molecular pharmacology.

[29]  L. Kozak,et al.  The mitochondrial uncoupling protein gene in brown fat: correlation between DNase I hypersensitivity and expression in transgenic mice , 1991, Molecular and cellular biology.

[30]  B. Spiegelman,et al.  A fat-specific enhancer is the primary determinant of gene expression for adipocyte P2 in vivo. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[31]  S. Woods,et al.  The Regulation of Food Intake by Peptides a , 1989, Annals of the New York Academy of Sciences.

[32]  A. Strosberg,et al.  Molecular characterization of the human beta 3-adrenergic receptor. , 1989, Science.

[33]  M. Sennitt,et al.  Atypical β-adrenoceptor on brown adipocytes as target for anti-obesity drugs , 1984, Nature.

[34]  J. Brobeck Food and temperature. , 1960, Recent progress in hormone research.

[35]  J. Brobeck,et al.  A Mechanism of Regulation of Food Intake * , 1953, The Yale journal of biology and medicine.